Srinivasan Sanjay

Dr. Srinivasan Sanjay

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2021 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
SMSai Bhakti Mishra
Sai Bhakti Mishra
PMPadmamalini Mahendradas
Padmamalini Mahendradas
AKAnkush Kawali
Ankush Kawali
SSSrinivasan Sanjay
Srinivasan Sanjay
RSRohit Shetty
Rohit Shetty
Purpose: To present the clinical features of a rare case of varicella zoster infection following one dose of Coronavirus Disease 2019 (COVID-19) vaccination in an elderly Asian Indian male. Methods: Retrospective observational case report. Results: A 71-year-old gentleman presented to us with complaints of reduced vision associated with redness and pain in his right eye for 1 week. On examination he revealed a right eye pan uveitis picture with circumcorneal congestion, multiple fine keratic precipitates, anterior chamber cells and flare, vitritis and widespread areas of acute retinal necrosis. His left eye was within normal limits. Ten days prior to the presentation he had received the first dose of COVID-19 vaccine following which he had developed fever for 2 days that preceded the red eye. The patient’s aqueous sample tested positive for varicella zoster virus (VZV) by nested polymerase chain reaction (PCR) method. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in reverse transcriptase polymerase chain reaction (RT-PCR) assay from the aqueous and also from the nasopharyngeal swab was negative. Conclusion and significance: To the best of our knowledge this is the earliest description of a case that has a viral reactivation following COVID-19 vaccination. Elderly people with pre-existing comorbidities, may be at a risk of both primary coronavirus infection and unconceivable risk of aberrant immune reactions leading to a different virus infection or reactivation need to be kept in mind. We present a possible link between SARS-CoV-2 virus vaccination and varicella zoster reactivation in this patient.

18 March 2021 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
SSSrinivasan Sanjay
Srinivasan Sanjay
PSPriya Srinivasan
Priya Srinivasan
CJChaitra Jayadev
Chaitra Jayadev
PMPadmamalini Mahendradas
Padmamalini Mahendradas
AGAditi Gupta
Aditi Gupta
RSRohit Shetty
Rohit Shetty
Introduction: The Ocular manifestations of coronavirus disease 2019 (COVID-19) reported include conjunctivitis, conjunctival hyperemia, chemosis, epiphora, episcleritis, retinal manifestations included cotton wool spots (CWS), micro-hemorrhages, papillophlebitis and neuro-ophthalmic manifestations.Purpose: To report post COVID-19 ophthalmic manifestations using multimodal imaging.Results: A 66-year-old Asian Indian male presented to us with bilateral blurring of vision, RE>LE, of 3 days following a diagnosis of COVID-19 disease. Corrected distance visual acuity were 20/2666 and 20/25 in the right (RE) and left (LE) eyes respectively. He had bilateral anterior chamber inflammation with a relative afferent pupillary defect in the RE. RE showed central retinal artery occlusion(CRAO) with CWS, few flame-shaped retinal hemorrhages and disc edema and hyperemia. LE had disc edema and hyperemia, few flame-shaped retinal hemorrhages, cystoid changes and CWS. A diagnosis of bilateral panuveitis and papillitis with CRAO in the RE was made.Conclusion: Our patient developed a vascular occlusion with panuveitis, which possibly represents an immune mediated event following COVID-19. Patients should be warned about possible ophthalmic sequelae even after recovery.

14 May 2021 in Journal of Ophthalmic Inflammation and Infection
Verified
Journal Article
Open access
PDF file
SSSrinivasan Sanjay
Srinivasan Sanjay
PGPoornachandra B. Gowda
Poornachandra B. Gowda
BRBhimasena Rao
Bhimasena Rao
DMDeepashri Mutalik
Deepashri Mutalik
PMPadmamalini Mahendradas
Padmamalini Mahendradas
RSRohit Shetty
Rohit Shetty
Introduction: Corona virus disease (COVID-19) pandemic can cause myriad of ocular manifestations. We report a case of unilateral multi focal central serous retinopathy, post COVID-19 infection in an Asian Indian female. Case presentation: A 42-year-old female presented to us with unilateral blurring, in the right eye (OD), 12 days after COVID-19 infection. She had fever, chills, shortness of breath and cough with tiredness and was COVID- RT PCR positive. She was administered intravenous and oral antibiotics with injection heparin/remdesivir, during her 7 day stay at the hospital. She was also on steroid inhalers. She had no systemic history of note. On ocular evaluation, her corrected distance visual acuity was 20/40 in OD and 20/20 in left eye (OS). Anterior segment was normal. Anterior vitreous was clear. Fundus examination of the OD showed central serous retinopathy (CSCR) with OS being normal. Conclusion: CSCR can occur post COVID-19 due to steroid administration and physicians administering it should be aware of this and refer the patients to an ophthalmologist earlier.

1 January 2020 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
PDF file
SSSrinivasan Sanjay
Srinivasan Sanjay
MSMuthu Sumitha
Muthu Sumitha
VKVasudha Kemmanu
Vasudha Kemmanu
MBMadhav Rao Bhanumathi
Madhav Rao Bhanumathi
RSRohit Shetty
Rohit Shetty

7 June 2021 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
SSSrinivasan Sanjay
Srinivasan Sanjay
DMDeepashri Mutalik
Deepashri Mutalik
SGSunil Gowda
Sunil Gowda
PMPadmamalini Mahendradas
Padmamalini Mahendradas
AKAnkush Kawali
Ankush Kawali
RSRohit Shetty
Rohit Shetty

1 December 2024 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
BMBALA MURUGAN
BALA MURUGAN
SSSrinivasan Sanjay
Srinivasan Sanjay
ASAnjana Somanath
Anjana Somanath
PMPadmamalini Mahendradas
Padmamalini Mahendradas
APAditya Patil
Aditya Patil
BGBharat Gurnani
Bharat Gurnani
In the dynamic field of ophthalmology, artificial intelligence (AI) is emerging as a transformative tool in managing complex conditions like uveitis. Characterized by diverse inflammatory responses, uveitis presents significant diagnostic and therapeutic challenges. This systematic review explores the role of AI in advancing diagnostic precision, optimizing therapeutic approaches, and improving patient outcomes in uveitis care. A comprehensive search of PubMed, Scopus, Google Scholar, Web of Science, and Embase identified over 10,000 articles using primary and secondary keywords related to AI and uveitis. Rigorous screening based on predefined criteria reduced the pool to 52 high-quality studies, categorized into six themes: diagnostic support algorithms, screening algorithms, standardization of Uveitis Nomenclature (SUN), AI applications in management, systemic implications of AI, and limitations with future directions. AI technologies, including machine learning (ML) and deep learning (DL), demonstrated proficiency in anterior chamber inflammation detection, vitreous haze grading, and screening for conditions like ocular toxoplasmosis. Despite these advancements, challenges such as dataset quality, algorithmic transparency, and ethical concerns persist. Future research should focus on developing robust, multimodal AI systems and fostering collaboration among academia and industry to ensure equitable, ethical, and effective AI applications. The integration of AI heralds a new era in uveitis management, emphasizing precision medicine and enhanced care delivery.